검색
Novartis AG
NVS관심 목록에 추가
159.870USD
+5.730+3.72%
종가 07/02, 13:00（ET）시세는 15분 지연됩니다
305.05B시가총액
22.75P/E TTM
자세한 내용은 Novartis AG 회사
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.
Novartis AG 정보
종목 코드 NVS
회사 이름Novartis AG
상장일May 07, 2001
CEONarasimhan (Vasant)
직원 수75883
유형Depository Receipt
회계 연도 종료May 07
주소Lichtstrasse 35
도시BASEL
증권 거래소NASDAQ OMX NASDAQ Basic NYSE
국가Switzerland
우편 번호4056
전화41613241111
웹사이트https://www.novartis.com/
종목 코드 NVS
상장일May 07, 2001
CEONarasimhan (Vasant)
Novartis AG의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Harry Kirsch
Mr. Harry Kirsch
Chief Financial Officer, Member of the Executive Committee
Chief Financial Officer, Member of the Executive Committee
--
--
Ms. Charlotte Pamer- Wieser, Ph.D.
Ms. Charlotte Pamer- Wieser, Ph.D.
Corporate Secretary
Corporate Secretary
--
--
Dr. Nancy C. Andrews, M.D., Ph.D.
Dr. Nancy C. Andrews, M.D., Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Ton Buechner
Mr. Ton Buechner
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Elizabeth (Liz) Doherty
Ms. Elizabeth (Liz) Doherty
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Vasant (Vas) Narasimhan, M.D.
Dr. Vasant (Vas) Narasimhan, M.D.
Chief Executive Officer, Member of the Executive Committee
Chief Executive Officer, Member of the Executive Committee
--
--
Mr. Frans van Houten
Mr. Frans van Houten
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Steffen Lang, Ph.D.
Dr. Steffen Lang, Ph.D.
President - Operations, Member of the Executive Committee
President - Operations, Member of the Executive Committee
--
--
Mr. Patrice Bula
Mr. Patrice Bula
Non-Executive Lead Independent Director
Non-Executive Lead Independent Director
--
--
Ms. Bridgette P. Heller
Ms. Bridgette P. Heller
Non-Executive Independent Director
Non-Executive Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Harry Kirsch
Mr. Harry Kirsch
Chief Financial Officer, Member of the Executive Committee
Chief Financial Officer, Member of the Executive Committee
--
--
Ms. Charlotte Pamer- Wieser, Ph.D.
Ms. Charlotte Pamer- Wieser, Ph.D.
Corporate Secretary
Corporate Secretary
--
--
Dr. Nancy C. Andrews, M.D., Ph.D.
Dr. Nancy C. Andrews, M.D., Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Ton Buechner
Mr. Ton Buechner
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Elizabeth (Liz) Doherty
Ms. Elizabeth (Liz) Doherty
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Vasant (Vas) Narasimhan, M.D.
Dr. Vasant (Vas) Narasimhan, M.D.
Chief Executive Officer, Member of the Executive Committee
Chief Executive Officer, Member of the Executive Committee
--
--
자주 묻는 질문
Novartis AG의 상위 5대 주주는 누구인가요?
Novartis AG의 상위 5대 주주는 다음과 같습니다: Mr. Harry Kirsch
Novartis AG(NVS)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, Novartis AG의 주식을 보유한 기관은 총 2164곳이며, 이들이 보유한 주식의 총 가치는 약 143.01M로 전체 발행 주식의 7.49%를 차지합니다. 이는 2025Q4 대비 -1630148.00 증가한 수치입니다.
Novartis AG의 최대 수익원은 무엇인가요?
2026Q1 기준, Novartis AG의 Rest of portfolio 부문이 가장 높은 매출을 기록했으며, 금액은 10.02B로 전체 매출의 18.37%를 차지했습니다.